Concert Pharmaceuticals Inc (CNCE) Return on Assets ROA from the third quarter of 2022 to third quarter of 2021 and for the year 2022, Average High and Low, Fundamental Ratios from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Concert Pharmaceuticals Inc   (NASDAQ: CNCE)


Concert Pharmaceuticals Inc 's ROA from the third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Concert Pharmaceuticals Inc 's ROA in the third quarter of 2022?
Concert Pharmaceuticals Inc recorded a cumulative net loss of $-186 million during 12 months ending in the third quarter of 2022, resulting in a negative return on assets (ROA) of -115.99%.

However, within the Healthcare sector 1026 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2022 quarter, so far to 5330, from total ROA ranking in the second quarter of 2022 at 5503.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Total Assets Change 33.2 % 18.28 % -7.3 % 3.45 % -16.26 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -186 -210 -175 -160 -88
Return On Assets (TTM) -115.99 % -140.63 % -122.86 % -110.34 % -60.93 %
CNCE's Total Ranking # 5330 # 5503 # 5407 # 5714 # 4502
Total Assets (TTM) in million 171 176 129 165 128
Seq. Total Assets Change -2.91 % 36.58 % -21.75 % 28.36 % -13.78 %
Seq. Net Income Change - - - - -

CNCE's 5 Years Annual ROA >> Back to CNCE Management Effectiveness >> Compare CNCE ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 503
Sector # 1027
Overall # 5221

Return On Assets Statistics
High Average Low
53.43 %
-44.9 %
-140.19 %
(Jun 30 2018)   (Jun 30 2022)





Financial Statements
Concert Pharmaceuticals Inc 's Assets $ 171 million CNCE's Balance sheet
Concert Pharmaceuticals Inc 's Income $ -29 million Quarterly CNCE's Income Statement
CNCE's Income by Division See CNCE's Income by Division



Annual Return On Assets (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017
Y / Y Total Assets Change 3.45 % 15.72 % -28.6 % -9.06 % 110.9 %
Total Assets in million 165 159 137 193 212
Y / Y Net Income Change - 150 % - - -
Net Income in million -160 0 0 0 95
Annual Return On Assets -97.28 % 0.05 % 0.02 % -0.16 % 44.96 %

CNCE's 5 Years Annual ROA >> Back to CNCE Management Effectiveness >> Compare CNCE ROA to its Competitors



More Return On Assets Ratios
CNCE's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CNCE's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CNCE's Competitors
Subscribers only: Roa for Concert Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for CNCE's Customers

You may also want to know
CNCE's Roi CNCE's Inventory Turnover Ratio CNCE's Growth Rates CNCE's Dividend Comparisons
CNCE's Profitability Ratios CNCE's Asset Turnover Ratio CNCE's Dividend Growth
CNCE's Roe CNCE's Valuation Ratios CNCE's Financial Strength Ratios CNCE's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2022, within Healthcare Sector ROA

Date modified: 2026-09-18T13:11:05+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.